Featured Research

from universities, journals, and other organizations

Researchers Find Drug May Help Cystic Fibrosis Patients

Date:
November 18, 1997
Source:
Johns Hopkins Children's Center
Summary:
Researchers at the Johns Hopkins Children’s Center have found that a drug used to normalize blood ammonia levels may also hold promise for cystic fibrosis.

Researchers at the Johns Hopkins Children’s Center have found that a drug used to normalize blood ammonia levels also holds promise for cystic fibrosis.

People with cystic fibrosis have mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene, which normally codes for a protein that transports chloride across the cell membrane.

Approximately 70% of cystic fibrosis patients have the same mutation (called the deltaF508 mutation) in this gene, which results in a protein that is partly functional but that rarely gets transported to the surface of the cell. Instead, this protein become “stuck” on the way to the surface and is degraded. Consequently, little or no chloride can be transported across the cell membrane. In cystic fibrosis, this chloride imbalance results in a thick mucus that causes recurrent airway and intestinal obstructions, as well as chronic respiratory infections.

The addition of sodium 4-phenylbutyrate (4PBA) to cells with the deltaF508 mutation allows more CFTR proteins to reach cell surfaces, where they can transport chloride, according to Ronald C. Rubenstein, M.D., Ph.D., an instructor in pediatrics at Hopkins and lead author of the study. This phenomenon occurs at concentrations of 4PBA normally seen in patients who already take the drug for urea cycle disorders, which are genetic diseases characterized by high levels of ammonia in the bloodstream.

The study appears in the November 15 issue of the Journal of Clinical Investigation.

“A therapy directed at correcting the abnormal intracellular transport of the deltaF508 mutation is potentially beneficial to the majority of CF patients,” says Rubenstein. “We are very encouraged by 4PBA’s apparent action to repair this mutation’s function in the lab.”

Cystic fibrosis occurs in about one in every 2,500 births in the Caucasian population, one in every 16,000 births in the African American population, and about one in every 90,000 births in the Asian American population.

“There are currently an estimated 23,000 patients diagnosed with CF in the United States, with an average survival age of 31 years,” says Pamela Zeitlin, M.D., Ph.D., associate professor of pediatrics at Johns Hopkins and a co-author of the study. “4PBA has the potential to benefit more than two-thirds of these patients.”

However, say Rubenstein and Zeitlin, it is not clear if this therapy alone would lead to significant improvement in patients. Even if the mutant proteins reach cell surfaces, they still cannot transport as much chloride as normal proteins do.

Rubenstein and Zeitlin are currently conducting clinical trials of 4PBA in CF patients who have the deltaF508 mutation.

Marie E. Egan, M.D., of Yale University, is also an author of the study.

The Johns Hopkins Children’s Center is the children’s hospital of the Johns Hopkins medical institutions. Maryland’s most comprehensive acute-care hospital for children, the center, with its 177-bed hospital and more than 40 divisions and services, treats some 8,000 inpatients and more than 64,000 outpatients annually.


Story Source:

The above story is based on materials provided by Johns Hopkins Children's Center. Note: Materials may be edited for content and length.


Cite This Page:

Johns Hopkins Children's Center. "Researchers Find Drug May Help Cystic Fibrosis Patients." ScienceDaily. ScienceDaily, 18 November 1997. <www.sciencedaily.com/releases/1997/11/971118132237.htm>.
Johns Hopkins Children's Center. (1997, November 18). Researchers Find Drug May Help Cystic Fibrosis Patients. ScienceDaily. Retrieved September 16, 2014 from www.sciencedaily.com/releases/1997/11/971118132237.htm
Johns Hopkins Children's Center. "Researchers Find Drug May Help Cystic Fibrosis Patients." ScienceDaily. www.sciencedaily.com/releases/1997/11/971118132237.htm (accessed September 16, 2014).

Share This



More Health & Medicine News

Tuesday, September 16, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

President To Send 3,000 Military Personnel To Fight Ebola

President To Send 3,000 Military Personnel To Fight Ebola

Newsy (Sep. 16, 2014) President Obama is expected to send 3,000 troops to West Africa as part of the effort to contain Ebola's spread. Video provided by Newsy
Powered by NewsLook.com
Man Floats for 31 Hours in Gulf Waters

Man Floats for 31 Hours in Gulf Waters

AP (Sep. 16, 2014) A Texas man is lucky to be alive after he and three others floated for more than a day in the Gulf of Mexico when their boat sank during a fishing trip. (Sept. 16) Video provided by AP
Powered by NewsLook.com
Ivorians Abandon Monkey Pets in Fear Over Ebola Virus

Ivorians Abandon Monkey Pets in Fear Over Ebola Virus

AFP (Sep. 16, 2014) Since the arrival of Ebola in Ivory Coast, Ivorians have been abandoning their pets, particularly monkeys, in the fear that they may transmit the virus. Duration: 00:47 Video provided by AFP
Powered by NewsLook.com
Study Links Male-Pattern Baldness To Prostate Cancer

Study Links Male-Pattern Baldness To Prostate Cancer

Newsy (Sep. 16, 2014) New findings suggest men with a certain type of baldness at age 45 are 39 percent more likely to develop aggressive prostate cancer. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

    Environment News

      Technology News



      Save/Print:
      Share:

      Free Subscriptions


      Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

      Get Social & Mobile


      Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

      Have Feedback?


      Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
      Mobile: iPhone Android Web
      Follow: Facebook Twitter Google+
      Subscribe: RSS Feeds Email Newsletters
      Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins